Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial

Thomas Powles, Kobe Yuen, Silke Gillessen, Edward E. Kadel, Dana E. Rathkopf, Nobuaki Matsubara, Charles G. Drake, Karim Fizazi, Josep M. Piulats, Piotr J. Wysocki, Gary L. Buchschacher, B. Yа. Alekseev, Begoña Mellado, Bogusława Karaszewska, Jennifer Doss, Grozdana Rasuo, Asim Datye, Sanjeev Mariathasan, Patrick Williams, Christopher J. Sweeney